- Home
- FNKO vs PLRX Comparison
FNKO vs PLRX Comparison
Compare FNKO & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNKO
- PLRX
- Stock Information
- Founded
- FNKO 2017
- PLRX 2015
- Country
- FNKO United States
- PLRX United States
- Employees
- FNKO N/A
- PLRX N/A
- Industry
- FNKO Recreational Games/Products/Toys
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- FNKO Consumer Discretionary
- PLRX Health Care
- Exchange
- FNKO Nasdaq
- PLRX Nasdaq
- Market Cap
- FNKO 708.1M
- PLRX 680.3M
- IPO Year
- FNKO 2017
- PLRX 2020
- Fundamental
- Price
- FNKO $13.92
- PLRX $11.37
- Analyst Decision
- FNKO Strong Buy
- PLRX Strong Buy
- Analyst Count
- FNKO 3
- PLRX 7
- Target Price
- FNKO $14.33
- PLRX $40.50
- AVG Volume (30 Days)
- FNKO 692.9K
- PLRX 485.5K
- Earning Date
- FNKO 03-06-2025
- PLRX 02-26-2025
- Dividend Yield
- FNKO N/A
- PLRX N/A
- EPS Growth
- FNKO N/A
- PLRX N/A
- EPS
- FNKO N/A
- PLRX N/A
- Revenue
- FNKO $1,047,357,000.00
- PLRX N/A
- Revenue This Year
- FNKO N/A
- PLRX N/A
- Revenue Next Year
- FNKO $7.90
- PLRX N/A
- P/E Ratio
- FNKO N/A
- PLRX N/A
- Revenue Growth
- FNKO N/A
- PLRX N/A
- 52 Week Low
- FNKO $5.36
- PLRX $10.22
- 52 Week High
- FNKO $14.65
- PLRX $18.00
- Technical
- Relative Strength Index (RSI)
- FNKO 55.42
- PLRX 44.60
- Support Level
- FNKO $13.31
- PLRX $10.35
- Resistance Level
- FNKO $14.23
- PLRX $11.07
- Average True Range (ATR)
- FNKO 0.57
- PLRX 0.61
- MACD
- FNKO -0.02
- PLRX 0.06
- Stochastic Oscillator
- FNKO 56.45
- PLRX 43.50
About FNKO Funko Inc.
Funko Inc is an us-based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.